March 10 (Reuters) - Illumina ILMN.O is reducing its annual forecast and cutting $100 million in spending because China barred sales of the company's gene-sequencing machines, the Wall Street Journal reported on Monday, citing the company's Chief Financial Officer Ankur Dhingra.
(Reporting by Sneha S K; Editing by Alan Barona)
((Sneha.SK@thomsonreuters.com))